Pharmaceutical Research
1991-04-01
In vitro binding of lorazepam and lorazepam glucuronide to cholestyramine, colestipol, and activated charcoal.
R J Herman, A Chaudhary
Index: Pharm. Res. 8(4) , 538-40, (1991)
Full Text: HTML
Abstract
Related Articles:
Commentary on: Dou C, Bournique J, Zinda M, Gnezda M, Nally A, Salamone S. Comparison of rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and temazepam-glucuronide catalyzed by E. coli beta-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer.
2002-03-01
[J. Forensic Sci. 47(2) , 427-8, (2002)]
Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
2005-02-01
[Am. J. Kidney Dis. 45(2) , 360-71, (2005)]
Biotransformation and excretion of lorazepam in patients with chronic renal failure.
1976-12-01
[Br. J. Clin. Pharmacol. 3(6) , 1033-9, (1976)]
Analysis of lorazepam and its 30-glucuronide in human urine by capillary electrophoresis: evidence for the formation of two distinct diastereoisomeric glucuronides.
2006-01-01
[J. Sep. Sci. 29(1) , 153-63, (2006)]
Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples.
2006-02-13
[J. Pharm. Biomed. Anal. 40(2) , 389-96, (2006)]